<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Nasdaq Trade System - Lyell Immunopharma, Inc. - Common Stock</title>
    <!-- Latest compiled and minified CSS -->
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.6/dist/css/bootstrap.min.css" rel="stylesheet"
          integrity="sha384-4Q6Gf2aSP4eDXB8Miphtr37CMZZQ5oXLH2yaXMJ2w8e2ZtHTl7GptT4jmndRuHDT" crossorigin="anonymous">
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.6/dist/js/bootstrap.bundle.min.js"
            integrity="sha384-j1CDi7MgGQ12Z7Qab0qlWQ/Qqz24Gc6BM0thvEMVjHnfYGF0rmFCozFSxQBxwHKO"
            crossorigin="anonymous"></script>
    <meta name="theme-color" content="#712cf9">
</head>

<body>
<header class="navbar sticky-top bg-dark flex-md-nowrap p-0 shadow" data-bs-theme="dark"><a
        class="navbar-brand col-md-3 col-lg-2 me-0 px-3 fs-6 text-white" href="#">Nasdaq Trade system</a>
</header>


<div class="container-fluid">
    <div class="row">

        <main class="col-md-9 ms-sm-auto col-lg-10 px-md-4">
            <a href="../GameResult.html">Back</a>
            <h1>Lyell Immunopharma, Inc. - Common Stock</h1>
            <img src="LYEL.png" class="img-fluid">
            
            <div class="table-responsive small">
                <table class="table table-striped table-sm">
                    <thead>
                    <tr>
                        <th scope="col">ExecutedOn</th>
                        <th scope="col">Company</th>
                        <th scope="col">Listing</th>
                        <th scope="col">Amount</th>
                        <th scope="col">AtPrice</th>
                        <th scope="col">Total</th>
                    </tr>
                    </thead>
                    <tbody>
                    <tr scope="row">
                        <td>08-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>302</td>
                        <td>$305.00</td>
                        <td>$92,110.00</td>
                    </tr>
                    <tr scope="row">
                        <td>09-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-302</td>
                        <td>$317.60</td>
                        <td>-$95,915.20</td>
                    </tr>
                    <tr scope="row">
                        <td>13-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>303</td>
                        <td>$324.40</td>
                        <td>$98,293.20</td>
                    </tr>
                    <tr scope="row">
                        <td>14-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-303</td>
                        <td>$333.40</td>
                        <td>-$101,020.20</td>
                    </tr>
                    <tr scope="row">
                        <td>15-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>321</td>
                        <td>$321.40</td>
                        <td>$103,169.40</td>
                    </tr>
                    <tr scope="row">
                        <td>16-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-321</td>
                        <td>$338.20</td>
                        <td>-$108,562.20</td>
                    </tr>
                    <tr scope="row">
                        <td>28-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>469</td>
                        <td>$270.20</td>
                        <td>$126,723.81</td>
                    </tr>
                    <tr scope="row">
                        <td>29-07-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-469</td>
                        <td>$279.40</td>
                        <td>-$131,038.60</td>
                    </tr>
                    <tr scope="row">
                        <td>02-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>542</td>
                        <td>$294.40</td>
                        <td>$159,564.80</td>
                    </tr>
                    <tr scope="row">
                        <td>03-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-542</td>
                        <td>$311.00</td>
                        <td>-$168,562.00</td>
                    </tr>
                    <tr scope="row">
                        <td>04-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>549</td>
                        <td>$314.40</td>
                        <td>$172,605.60</td>
                    </tr>
                    <tr scope="row">
                        <td>05-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-549</td>
                        <td>$325.80</td>
                        <td>-$178,864.19</td>
                    </tr>
                    <tr scope="row">
                        <td>12-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>690</td>
                        <td>$285.60</td>
                        <td>$197,064.00</td>
                    </tr>
                    <tr scope="row">
                        <td>13-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-690</td>
                        <td>$296.20</td>
                        <td>-$204,378.01</td>
                    </tr>
                    <tr scope="row">
                        <td>16-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>725</td>
                        <td>$281.60</td>
                        <td>$204,160.00</td>
                    </tr>
                    <tr scope="row">
                        <td>17-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-725</td>
                        <td>$294.60</td>
                        <td>-$213,585.00</td>
                    </tr>
                    <tr scope="row">
                        <td>19-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>758</td>
                        <td>$290.80</td>
                        <td>$220,426.39</td>
                    </tr>
                    <tr scope="row">
                        <td>20-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-758</td>
                        <td>$302.80</td>
                        <td>-$229,522.39</td>
                    </tr>
                    <tr scope="row">
                        <td>26-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>795</td>
                        <td>$305.80</td>
                        <td>$243,110.99</td>
                    </tr>
                    <tr scope="row">
                        <td>27-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-795</td>
                        <td>$324.60</td>
                        <td>-$258,057.00</td>
                    </tr>
                    <tr scope="row">
                        <td>31-08-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>835</td>
                        <td>$315.80</td>
                        <td>$263,692.99</td>
                    </tr>
                    <tr scope="row">
                        <td>01-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-835</td>
                        <td>$322.00</td>
                        <td>-$268,870.00</td>
                    </tr>
                    <tr scope="row">
                        <td>01-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>835</td>
                        <td>$322.00</td>
                        <td>$268,870.00</td>
                    </tr>
                    <tr scope="row">
                        <td>02-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-835</td>
                        <td>$334.00</td>
                        <td>-$278,890.00</td>
                    </tr>
                    <tr scope="row">
                        <td>09-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>869</td>
                        <td>$337.20</td>
                        <td>$293,026.81</td>
                    </tr>
                    <tr scope="row">
                        <td>10-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-869</td>
                        <td>$359.00</td>
                        <td>-$311,971.00</td>
                    </tr>
                    <tr scope="row">
                        <td>23-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$224.60</td>
                        <td>$224,600.01</td>
                    </tr>
                    <tr scope="row">
                        <td>24-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$245.60</td>
                        <td>-$245,600.01</td>
                    </tr>
                    <tr scope="row">
                        <td>27-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$256.80</td>
                        <td>$256,799.99</td>
                    </tr>
                    <tr scope="row">
                        <td>28-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$282.40</td>
                        <td>-$282,399.99</td>
                    </tr>
                    <tr scope="row">
                        <td>29-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$291.20</td>
                        <td>$291,200.01</td>
                    </tr>
                    <tr scope="row">
                        <td>30-09-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$296.00</td>
                        <td>-$296,000.00</td>
                    </tr>
                    <tr scope="row">
                        <td>06-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$231.40</td>
                        <td>$231,399.99</td>
                    </tr>
                    <tr scope="row">
                        <td>07-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$249.00</td>
                        <td>-$249,000.00</td>
                    </tr>
                    <tr scope="row">
                        <td>07-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$249.00</td>
                        <td>$249,000.00</td>
                    </tr>
                    <tr scope="row">
                        <td>08-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$258.80</td>
                        <td>-$258,799.99</td>
                    </tr>
                    <tr scope="row">
                        <td>18-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$261.60</td>
                        <td>$261,600.01</td>
                    </tr>
                    <tr scope="row">
                        <td>19-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$278.40</td>
                        <td>-$278,399.99</td>
                    </tr>
                    <tr scope="row">
                        <td>25-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$289.00</td>
                        <td>$289,000.00</td>
                    </tr>
                    <tr scope="row">
                        <td>26-10-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$303.80</td>
                        <td>-$303,799.99</td>
                    </tr>
                    <tr scope="row">
                        <td>16-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$218.80</td>
                        <td>$218,800.00</td>
                    </tr>
                    <tr scope="row">
                        <td>17-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$222.00</td>
                        <td>-$222,000.00</td>
                    </tr>
                    <tr scope="row">
                        <td>18-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$210.40</td>
                        <td>$210,399.99</td>
                    </tr>
                    <tr scope="row">
                        <td>19-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$216.20</td>
                        <td>-$216,200.00</td>
                    </tr>
                    <tr scope="row">
                        <td>29-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$185.00</td>
                        <td>$185,000.00</td>
                    </tr>
                    <tr scope="row">
                        <td>30-11-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$191.00</td>
                        <td>-$191,000.00</td>
                    </tr>
                    <tr scope="row">
                        <td>07-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$183.60</td>
                        <td>$183,600.01</td>
                    </tr>
                    <tr scope="row">
                        <td>08-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$198.60</td>
                        <td>-$198,600.01</td>
                    </tr>
                    <tr scope="row">
                        <td>22-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$149.80</td>
                        <td>$149,800.00</td>
                    </tr>
                    <tr scope="row">
                        <td>23-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$164.20</td>
                        <td>-$164,200.00</td>
                    </tr>
                    <tr scope="row">
                        <td>29-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$142.60</td>
                        <td>$142,600.01</td>
                    </tr>
                    <tr scope="row">
                        <td>30-12-2021</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Lyell Immunopharma, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$151.00</td>
                        <td>-$151,000.00</td>
                    </tr>
                    </tbody>
                </table>
            </div>
        </main>
    </div>
</div>
</body>
</html>